Abstract
A. Varnavas and colleagues (16) have synthesized 1,3-di (4-carboxyphenyl) triazene (I), which is a diaryltriazene analogue of the antimetastatic agent DM-COOK (II).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Poster Titles
Mechanisms of the cross-protective immunity induced by xenogenized against parental cells. R. Bianchi, M.C. Fioretti, L. Romani, M. Allegrucci and P. Puccetti. Dept. Exp. Med. and Bioch. Sci., Pharmacology Section, University of 06100 Perugia, Italy.
Effects of Dacarbazine (DTIC) on immunology in the human: I: High intermittent dose (HID). G. Cartei1, T. Giraldi2 and R. Carella1. 1 Divisione di Oncologia Medica, Ospedale Regionale, Udine and 2 Istituto di Farmacología, Università di Trieste.
Effect of Dacarbazine (DTIC) on immunology in the human: II: Low and intermediate chronic dose schedule (LDC,ICD). G. Cartei1, T. Giraldi2 and R. Carella1. 1 Divisione di Oncologia Medica, Ospedale Regionale, Udine and 2 Istituto di Farmacología, Università di Trieste.
Allorecognition of antigenic modifications induced by 4 (3-methyl-l-triazeno) benzoic acid (MTBA) in a human tumor line. S. D’Atri1, M. Tricarico2 and E. Bonmassar1. 1 Dep. of Experimental Medicine and Biochemical Sciences. II University of Rome, Rome, Italy and 2 Institute of Experimental Medicine, CNR, Rome Italy.
Comparative analysis of xenogenization patterns by chemicals belonging to different classes. P. Fuschiotti, U. Grohmann, L. Romani, P. Puccetti and M. C. Fioretti. Dept. Exp. Med. and Bioch. Sci., Pharmacology Section, University of 06100 Perugia, Italy.
Combination of BCNU DTIC VCR alternating with eis DDP Vinblastin and Bleomycin as primary chemotherapy in metastatic melanoma- a phase II trial. K. Kolaric, R. Tomek, Z. Mrsic and D. Zupanc. Central Institute for Tumors and Allied Diseases, Zagreb, Yugoslavia.
Correlation between chemosensitivity to CB10–277 and O6-alkyl-guanine-DNA alkyltransferase levels in human melanoma xenografts. J. M. Lunn1, B. J. Foster2, M. Jones2, J. Siraky2 and D. R. Newell2. 1Cancer Research Unit, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, England and2 Clinical Pharmacology, Institute of Cancer Research, Sutton, Surrey SM2 5NG., England.
Antimetastatic effect of dimethyltriazenes in mice bearing Lewis lung carcinoma of different metastatic potential. E. Raso, K. Lapis and L. Kopper. I. Insitute of Pathology and Experimental Cancer Research, Semmelweis Medical University, Ulloi ut 26, Budapest, H-1085 Hungary.
Activation and oxidative (MFO) N-demethylation of ring halogenated 3,3-dimethyl-l-phenyltriazenes. G. Sava1, S. Pacor1, F. Bregant1, V. Ceschia1 and G. F. Kolar2. 1 Institute of Pharmacology, Faculty of Pharmacy, University of Trieste, 1–34100 Trieste, Italy and 2 Institute of Toxicology and Chemotherapy, German Cancer Research Center, D-6900 Heidelberg, F.R.G.
Antineoplastic action of p-(3-methyl-l-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK. G. Sava1, S. Zorzet1, L. Perissin1, S. Pacor1, V. Ceschia1, F. Bregant1, T. Giraldi1, A. Varnavas2, C. Nisi2 and L. Lassiani2. 1 Institute of Pharmacology and 2 Institute of Pharmaceutical Chemistry and Toxicology, Faculty of Pharmacy, University of Trieste, Italy.
Relation between methyltriazenes cytotoxicity and cell line ability to repair O6 alkylguanine. P. Taverna1, C. V. Catapano1, L. Citti2, M. Bonfanti1 and M. D’Incalci1. 1 Istituto “Mario Negri”, I–20157 Milano and 2 CNR Istituto Mutagenesi e Differenziamento, I–56100 Pisa.
Antitumor activity and aqueous stability of AVIS, a hydrosoluble diaryltriazene, related to the antimetastatic agent DM-COOK. A. Varnavas1, L. Lassiani1, C. Nisi1, S. Zorzet2, L. Perissin2 and G. Sava2. 1 Institute of Medicinal Chemistry and 2 Institute of Pharmacology, Faculty of Pharmacy, University of Trieste, Italy.
Synthesis and antitumor activity of hydrosoluble triazenes analogues of DM-COOK. A. Varnavas1, L. Lassiani1, C. Nisi1, S. Zorzet2, L. Perissin2, S. Pacor2, T. Giraldi2 and G. Sava2. 1 Institute of Medicinal Chemistry and 2 Institute of Pharmacology, Faculty of Pharmacy, University of Trieste, Italy.
Chromosome and DMA damage induced by the 1-p-(3-methyl-triazeno) benzoic acid potassium salt in human cells. P. Vernole1, D. Caporossi1, B. Tedeschi1, F. Zunino2, E. Bonmassar3 and B. Nicoletti1. 1 Dip. Sanità Pubblica & Biologia Cellulare, II Università di Roma, Via O. Raimondo 00173 Roma, Italia, 2 Ist. Naz. Studio & Cura Tumori, Milano, 3 Dip. Med. Sper., II Università di Roma.
Dacarbazine and Interferon alpha-2b combination in advanced malignant melanoma: a phase II study. S. Milani, G. Mustacchi, P. Sandri and M. Mansutti. Centro Oncológico, Via Pietà 19, 34127 Trieste, Italy.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bonmassar, E., Gescher, A., Newell, D.R., Stevens, M.F.G. (1990). Summary of Poster-Sessions. In: Giraldi, T., Connors, T.A., Cartei, G. (eds) Triazenes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3832-5_17
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3832-5_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6710-9
Online ISBN: 978-1-4615-3832-5
eBook Packages: Springer Book Archive